LAPTM5 and breast cancer: In this dataset, LAPTM5 also exhibited higher levels in breast cancer cells with high lung-specific metastatic activity (Lung-M) than in those with mediate activity (Mediate) and bone-specific metastatic activity (Bone-M) (Fig. 8b).